CoChat

Therapy for Stage IV Non–Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2023.3

Jaiyesimi, Ishmael A., Leighl, Natasha B., Ismaila, Nofisat, Alluri, Krishna, Florez, Narjust, Gadgeel, Shirish, Masters, Gregory, Schenk, Erin L., Schneider, Bryan J., Sequist, Lecia, Singh, Navneet, Bazhenova, Lyudmila, Blanchard, Elizabeth, Freeman-Daily, Janet, Furuya, Naoki, Halmos, Balazs, Azar, Ibrahim Hanna, Kuruvilla, Sara, Mullane, Michael, Naidoo, Jarushka, Reuss, Joshua E., Spigel, David R., Owen, Dwight H., Patel, Jyoti D. · 2024 · Journal of Clinical Oncology
Cited by 82

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

Abstract

Living guidelines are developed for selected topic areas with rapidly evolving evidence that drives frequent change in recommended clinical practice. Living guidelines are updated on a regular schedule by a standing expert panel that systematically reviews the health literature on a continuous basis, as described in the ASCO Guidelines Methodology Manual . ASCO Living Guidelines follow the ASCO Conflict of Interest Policy Implementation for Clinical Practice Guidelines . Living Guidelines and updates are not intended to substitute for independent professional judgment of the treating provider and do not account for individual variation among patients. See complete disclaimer in Appendix 1 and Appendix 2 for more. Updates are published regularly and can be found at https://ascopubs.org/nsclc-non-da-living-guideline . PURPOSE: To provide evidence-based recommendations for patients with stage IV non–small cell lung cancer (NSCLC) without driver alterations. METHODS: This ASCO living guideline offers continually updated recommendations based on an ongoing systematic review of randomized clinical trials (RCTs), with the latest time frame spanning February to October 2023. An Expert Panel of medical oncology, pulmonary, community oncology, research methodology, and advocacy experts were convened. The literature search included systematic reviews, meta-analyses, and randomized controlled trials. Outcomes of interest include efficacy and safety. Expert Panel members used available evidence and informal consensus to develop evidence-based guideline recommendations. RESULTS: This guideline consolidates all previous updates and reflects the body of evidence informing this guideline topic. Ten new RCTs were identified in the latest search of the literature to date. RECOMMENDATIONS: Evidence-based recommendations were updated to address first, second, and subsequent treatment options for patients without driver alterations. Additional information is available at www.asco.org/living-guidelines .

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1200/jco.23.02746

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 82

Metadata

Authors
Jaiyesimi, I. A., Leighl, N. B., Ismaila, N., Alluri, K., Florez, N., Gadgeel, S., Masters, G., Schenk, E. L., Schneider, B. J., Sequist, L., Singh, N., Bazhenova, L., Blanchard, E., Freeman-Daily, J., Furuya, N., Halmos, B., Azar, I. H., Kuruvilla, S., Mullane, M., Naidoo, J., Reuss, J. E., Spigel, D. R., Owen, D. H., & Patel, J. D.
Venue
Journal of Clinical Oncology
Published
2024-04-10
Volume
42
Issue
11
Pages
e23-e43
ISSN
  • 0732-183X (ISSN-L)
  • 1527-7755
OpenAlex
W4392243479
Cited by
82
References
17
FWCI
20.92
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.